Psychological, pharmacological, and combined smoking cessation interventions for smokers with current depression: A systematic review and meta-analysis

Roberto Secades-Villa, Alba González-Roz, Ángel García-Pérez, Elisardo Becoña, Roberto Secades-Villa, Alba González-Roz, Ángel García-Pérez, Elisardo Becoña

Abstract

We conducted a systematic literature review and meta-analysis (ID: CRD42016051017) of smoking cessation interventions for patients with current depression. We examined the effectiveness of smoking cessation treatments in improving abstinence rates and depressive symptoms. The following electronic databases were used for potentially eligible studies: PUBMED, PSYCINFO, DIALNET and WEB OF KNOWLEDGE. The search terms used were: smoking cessation, depressive disorder, depression, mood, depressive, depressed, smoking, smokers, nicotine, nicotine dependence, and tobacco cigarette smoking. The methodological quality of included studies was assessed using the Effective Public Health Practice Project Quality assessment tool (EPHPP). Of the 6,584 studies identified, 20 were eligible and included in the review. Trial designs of studies were 16 randomized controlled trials and 4 secondary studies. Studies included three types of intervention: psychological (6/30%), pharmacological (6/30%) or combined (8/40%). Four trials comprised special populations of smokers. Four studies received a strong methodological quality, 7 were scored as moderate and 9 studies received a weak methodological rating. Analyses of effectiveness showed that smoking cessation interventions appear to increase short-term and long-term smoking abstinence in individuals with current depression. Subgroup analyses revealed stronger effects among studies that provided pharmacological treatments than in studies using psychological treatments. However, the evidence is weak due to the small number of studies. Smoking abstinence appears to be associated with an improvement in depressive symptoms. Heterogeneity in protocols in similar types of treatment also prevent firm conclusions being drawn on the effectiveness of any particular treatment model to optimally manage abstinence among depressed smokers. Further research is required to strengthen the evidence base.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Literature search procedure.
Fig 1. Literature search procedure.
Fig 2. Psychological, pharmacological, or combined interventions.
Fig 2. Psychological, pharmacological, or combined interventions.
Fig 3. Psychological interventions.
Fig 3. Psychological interventions.
Fig 4. Pharmacological interventions.
Fig 4. Pharmacological interventions.

References

    1. World Health Organization. WHO Global Report. Mortality Attributable to Tobacco. Geneva: World Health Organization, 2012.
    1. Luger TM, Suls J, Vander Weg MW. How robust is the association between smoking and depression in adults? A meta-analysis using linear mixed-effects models. Addictive behaviors. 2014;39(10):1418–29. doi: .
    1. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. Jama. 2000;284(20):2606–10. doi: .
    1. Weinberger AH, Kashan RS, Shpigel DM, Esan H, Taha F, Lee CJ, et al. Depression and cigarette smoking behavior: a critical review of population-based studies. The American journal of drug and alcohol abuse. 2016:1–16. doi: .
    1. Breslau N, Peterson EL, Schultz LR, Chilcoat HD, Andreski P. Major depression and stages of smoking. A longitudinal investigation. Archives of general psychiatry. 1998;55(2):161–6. doi:
    1. Fluharty M, Taylor AE, Grabski M, Munafo MR. The Association of Cigarette Smoking With Depression and Anxiety: A Systematic Review. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2017;19(1):3–13. doi: .
    1. Gierisch JM, Bastian LA, Calhoun PS, McDuffie JR, Williams JW Jr. Smoking cessation interventions for patients with depression: a systematic review and meta-analysis. J Gen Intern Med. 2012;27(3):351–60. doi: .
    1. van der Meer RM, Willemsen MC, Smit F, Cuijpers P. Smoking cessation interventions for smokers with current or past depression. Cochrane Database of Systematic Reviews. 2013; (8):CD006102 doi:
    1. Secades-Villa R, Vallejo-Seco G, García-Rodríguez O, López-Núñez C, Weidberg S, González-Roz A. Contingency Management for Cigarette Smokers with Depressive Symptoms. Experimental and Clinical Psychopharmacology. 2015;23(5):351–60. doi:
    1. Blalock JA, Robinson JD, Wetter DW, Schreindorfer LS, Cinciripini PM. Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment. Psychology of addictive behaviors: journal of the Society of Psychologists in Addictive Behaviors. 2008;22(1):122–8. doi: .
    1. Mathew AR, Robinson JD, Norton PJ, Cinciripini PM, Brown RA, Blalock JA. Affective trajectories before and after a quit attempt among smokers with current depressive disorders. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2013;15(11):1807–15. doi: .
    1. Hitsman B, Papandonatos GD, McChargue DE, DeMott A, Herrera MJ, Spring B, et al. Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Addiction. 2013;108(2):294–306. doi: .
    1. Weinberger AH, Mazure CM, Morlett A, McKee SA. Two decades of smoking cessation treatment research on smokers with depression: 1990–2010. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2013;15(6):1014–31. doi: .
    1. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. Bmj. 2014;348:g1151 doi: .
    1. Prochaska JJ. Failure to treat tobacco use in mental health and addiction treatment settings: a form of harm reduction? Drug and alcohol dependence. 2010;110(3):177–82. doi: .
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine. 2009;151(4):264–9, W64 .
    1. Borenstein M, Rothstein H. Comprehensive meta analysis: A computer program for research synthesis. Englewood, NJ: Biostat, Inc; 1999.
    1. Prochaska JJ, Delucchi K, Hall SM. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. Journal of consulting and clinical psychology. 2004;72(6):1144–56. doi: .
    1. Fleiss JL. Analysis of data from multiclinic trials. Controlled clinical trials. 1986;7(4):267–75. .
    1. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to metaanalysis. Chichester, UK: Wiley; 2009.
    1. Armijo-Olivo S, Stiles CR, Hagen NA, Biondo PD, Cummings GG. Assessment of study quality for systematic reviews: a comparison of the Cochrane Collaboration Risk of Bias Tool and the Effective Public Health Practice Project Quality Assessment Tool: methodological research. Journal of evaluation in clinical practice. 2012;18(1):12–8. doi: .
    1. Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. Health technology assessment. 2003;7(27):iii–x, 1–173. .
    1. Cinciripini PM, Blalock JA, Minnix JA, Robinson JD, Brown VL, Lam C, et al. Effects of an intensive depression-focused intervention for smoking cessation in pregnancy. Journal of consulting and clinical psychology. 2010;78(1):44–54. doi: .
    1. Hall SM, Tsoh JY, Prochaska JJ, Eisendrath S, Rossi JS, Redding CA, et al. Treatment for cigarette smoking among depressed mental health outpatients: a randomized clinical trial. American journal of public health. 2006;96(10):1808–14. doi: .
    1. Japuntich SJ, Smith SS, Jorenby DE, Piper ME, Fiore MC, Baker TB. Depression predicts smoking early but not late in a quit attempt. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2007;9(6):677–86. doi: .
    1. Hayes RB, Dunsiger S, Borrelli B. The influence of quality of life and depressed mood on smoking cessation among medically ill smokers. Journal of behavioral medicine. 2010;33(3):209–18. doi: .
    1. Munoz RF, Barrera AZ, Delucchi K, Penilla C, Torres LD, Perez-Stable EJ. International Spanish/English Internet smoking cessation trial yields 20% abstinence rates at 1 year. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2009;11(9):1025–34. doi: .
    1. Munoz RF, Lenert LL, Delucchi K, Stoddard J, Perez JE, Penilla C, et al. Toward evidence-based Internet interventions: A Spanish/English Web site for international smoking cessation trials. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2006;8(1):77–87. doi: .
    1. Munoz RF, Marin BV, Posner SF, Perez-Stable EJ. Mood management mail intervention increases abstinence rates for Spanish-speaking Latino smokers. American journal of community psychology. 1997;25(3):325–43. .
    1. van der Meer RM, Willemsen MC, Smit F, Cuijpers P, Schippers GM. Effectiveness of a mood management component as an adjunct to a telephone counselling smoking cessation intervention for smokers with a past major depression: a pragmatic randomized controlled trial. Addiction. 2010;105(11):1991–9. doi: .
    1. Bernard P, Ninot G, Cyprien F, Courtet P, Guillaume S, Georgescu V, et al. Exercise and Counseling for Smoking Cessation in Smokers With Depressive Symptoms: A Randomized Controlled Pilot Trial. Journal of dual diagnosis. 2015;11(3–4):205–16. doi: .
    1. Vickers KS, Patten CA, Lewis BA, Clark MM, Ussher M, Ebbert JO, et al. Feasibility of an exercise counseling intervention for depressed women smokers. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2009;11(8):985–95. doi: .
    1. Patten CA, Bronars CA, Vickers Douglas KS, Ussher MH, Levine JA, Tye SJ, et al. Supervised, Vigorous Intensity Exercise Intervention for Depressed Female Smokers: A Pilot Study. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2017;19(1):77–86. doi: .
    1. Anthenelli RM, Morris C, Ramey TS, Dubrava SJ, Tsilkos K, Russ C, et al. Effects of varenicline on smoking cessation in adults with stably treated current or past major depression: a randomized trial. Annals of internal medicine. 2013;159(6):390–400. doi: .
    1. Kinnunen T, Korhonen T, Garvey AJ. Role of nicotine gum and pretreatment depressive symptoms in smoking cessation: twelve-month results of a randomized placebo controlled trial. International journal of psychiatry in medicine. 2008;38(3):373–89. doi: .
    1. Minami H, Kahler C, Bloom E, Strong D, Abrantes A, Zywiak W, et al. Effects of depression history and sex on the efficacy of sequential versus standard fluoxetine for smoking cessation in elevated depressive symptom smokers. Addictive Disorders & Their Treatment. 2015;14(1):29–39. doi:
    1. Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, et al. A bupropion smoking cessation clinical trial for cancer patients. Cancer causes & control: CCC. 2010;21(6):811–20. doi: .
    1. Thorsteinsson HS, Gillin JC, Patten CA, Golshan S, Sutton LD, Drummond S, et al. The effects of transdermal nicotine therapy for smoking cessation on depressive symptoms in patients with major depression. Neuropsychopharmacology. 2001;24(4):350–8. doi: .
    1. Ward KD, Asfar T, Al Ali R, Rastam S, Weg MW, Eissenberg T, et al. Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics. Addiction. 2013;108(2):394–403. doi: .
    1. Evins AE, Culhane MA, Alpert JE, Pava J, Liese BS, Farabaugh A, et al. A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. Journal of clinical psychopharmacology. 2008;28(6):660–6. doi: .
    1. Catley D, Ahluwalia JS, Resnicow K, Nazir N. Depressive symptoms and smoking cessation among inner-city African Americans using the nicotine patch. Nicotine & tobacco research: official journal of the Society for Research on Nicotine and Tobacco. 2003;5(1):61–8. .
    1. McFall M, Saxon AJ, Malte CA, Chow B, Bailey S, Baker DG, et al. Integrating tobacco cessation into mental health care for posttraumatic stress disorder: a randomized controlled trial. Jama. 2010;304(22):2485–93. doi: .
    1. Lancaster T, Stead LF. Self-help interventions for smoking cessation. The Cochrane database of systematic reviews. 2005; (3):CD001118 doi: .
    1. Ussher MH, Taylor AH, Faulkner GE. Exercise interventions for smoking cessation. The Cochrane database of systematic reviews. 2014; (8):CD002295 doi: .
    1. Ledgerwood DM. Contingency management for smoking cessation: where do we go from here? Curr Drug Abuse Rev. 2008;1(3):340–9. .
    1. Sigmon SC, Patrick ME. The use of financial incentives in promoting smoking cessation. Prev Med. 2012;55 Suppl:S24–32. doi: .
    1. Cahill K, Hartmann-Boyce J, Perera R. Incentives for smoking cessation. The Cochrane database of systematic reviews. 2015; (5):CD004307 doi: .
    1. Cahill K, Stevens S, Lancaster T. Pharmacological treatments for smoking cessation. Jama. 2014;311(2):193–4. doi: .
    1. Mills EJ, Wu P, Lockhart I, Thorlund K, Puhan M, Ebbert JO. Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis. Annals of medicine. 2012;44(6):588–97. doi: .
    1. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, et al. Inhibition of monoamine oxidase B in the brains of smokers. Nature. 1996;379(6567):733–6. doi: .
    1. Prochazka AV, Weaver MJ, Keller RT, Fryer GE, Licari PA, Lofaso D. A randomized trial of nortriptyline for smoking cessation. Arch Intern Med. 1998;158(18):2035–9. .
    1. Hall SM, Prochaska JJ. Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings. Annual review of clinical psychology. 2009;5:409–31. doi: .
    1. Hitsman B, Moss TG, Montoya ID, George TP. Treatment of tobacco dependence in mental health and addictive disorders. Canadian journal of psychiatry Revue canadienne de psychiatrie. 2009;54(6):368–78. doi: .

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner